(Brussels, Belgium) – – – – Kidney Disease: Improving Global Outcomes (KDIGO) is proud to announce an addition to its professional staff. Amy Earley has joined the KDIGO team as Guideline Development Director, bringing the total number of KDIGO staff to six. Amy will oversee KDIGO’s guideline development program under the guidance of KDIGO Chief Scientific Officer, Michael Cheung, and officially started on January 2, 2019.

KDIGO currently has two new guidelines in the pipeline, and two guideline updates underway. Amy will work closely with the evidence review team at Cochrane Kidney and Transplant, and with the four volunteer guideline work groups.

Amy has extensive experience in the field of clinical practice guidelines. She was previously at Tufts Medical Center in Boston working with both the Center for Guideline Development and Implementation as well as the Center for Clinical Evidence Synthesis. At Tufts, she was involved in the evidence review for several KDIGO guidelines. She later joined the Evidence Review Team at Brown University, while also serving as a Senior Research Associate at two Health Economics and Outcomes Research consulting firms in the Real World Strategy and Analytics, and MetaResearch departments, respectively.

“It is an honor and a thrill to be appointed Guideline Development Director. My hope is that I can bring both my methodological background and empirical insights in guideline development to the process to ensure and enhance the continued success and impact of KDIGO guidelines.”

“It is an honor and a thrill to be appointed Guideline Development Director,” said Amy. “My hope is that I can bring both my methodological background and empirical insights in guideline development to the process to ensure and enhance the continued success and impact of KDIGO guidelines,” she added.

Amy’s experience will help KDIGO to continue its mission of improving the care and outcomes of kidney disease patients worldwide through the development and implementation of global clinical practice guidelines. She is familiar with the GRADE system of evidence rating and KDIGO guideline methodology from participation in the development of 17 guidelines while at Tufts and Brown, and has developed extensive skills in methods of evidence-based medicine including both systematic review and evidence synthesis. A graduate of Lafayette College, Amy began her career at the Children’s Hospital of Philadelphia and the University of Pennsylvania Center for Clinical Epidemiology and Biostatistics.

“We are extremely pleased to have Amy joining us. The pace of KDIGO guidelines is picking up and Amy will help us ensure that our volunteer work groups are well organized, efficient, and focused on the best science.”

Michael Cheung, Chief Science Officer at KDIGO, said, “We are extremely pleased to have Amy joining us. The pace of KDIGO guidelines is picking up and Amy will help us ensure that our volunteer work groups are well organized, efficient, and focused on the best science.”

“Amy will go right to work on our guidelines since she is well acquainted with the processes involved. She will help prepare guidelines and updates for publication and support the overall mission of KDIGO,” Cheung added.

The team has already incorporated Amy into its work and looks forward to her valuable contributions.

KDIGO is a Belgian foundation committed to developing and implementing nephrology guidelines that improve patient outcomes on a global basis.

For further information please contact KDIGO at [email protected].

# # #